Top

World Journal of Emergency Surgery

Published in:

Open Access 01-12-2006 | Case report

A case report of a new pulmonary embolism occurring in a patient receiving continuous infusion of recombinant activated protein C

Authors: Bernard J Benedetto, Michael A Houston

Published in: World Journal of Emergency Surgery | Issue 1/2006

Abstract

Background

There are no guidelines governing the concomitant use of recombinant human activated protein C (rhAPC) and deep venous thrombosis/pulmonary embolism (DVT/PE) prophylaxis in critically ill patients. It is unknown if rhAPC provides any protection against DVT/PE in this population of patients.

Methods

Case report.

Results

This report describes the first case of a radiographically demonstrated pulmonary embolism occurring in a patient receiving continuous therapeutic infusion of rhAPC.

Conclusion

The administration of rhAPC alone may not be sufficient DVT/PE prophylaxis in high risk patients. The risks associated with concomitant anticoagulation and rhAPC therapy are unknown. Further research is necessary to determine the safest and most effective regimen for DVT/PE prophylaxis in patients receiving rhAPC.

Available only for authorised users

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garner GE, Helterbrand JD, Ely EW, Fisher CJ: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001, 344: 699-709. 10.1056/NEJM200103083441001.CrossRefPubMed

Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W: Activation of endothelial cell protease activated by protein C pathway. Science. 2002, 296: 1880-1882. 10.1126/science.1071699.CrossRefPubMed

Pingleton SK, Bone RC, Pingleton WW, Ruth WE: Prevention of pulmonary emboli in a respiratory intensive care unit: efficacy of low-dose heparin. Chest. 1981, 79: 647-650.CrossRefPubMed

Cade JF: High risk of the critically ill for venous thromboembolism. Crit Care Med. 1982, 10: 448-450.CrossRefPubMed

Halkin H, Goldberg J, Modan M: Reduction in general medical inpatients by low dose heparin prophylaxis. Ann Int Med. 1982, 96: 561-565.CrossRefPubMed

Hirsch DR, Ingenito EP, Goldhaber SZ: Prevalence of deep venous thrombosis among patients in medical intensive care. J Am Med Assoc. 1995, 274: 335-337. 10.1001/jama.274.4.335.CrossRef

Belch JJ, Lowe GD, Ward AG: Prevention of deep venous thrombosis in medical patients by low-dose heparin. Scott Med J. 1981, 26: 115-117.PubMed

Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Eng J Med. 1999, 341: 793-800. 10.1056/NEJM199909093411103.CrossRef

Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004, 32: 858-871. 10.1097/01.CCM.0000117317.18092.E4.CrossRefPubMed

10.

Dhainaut JF, Laterre PF, Janes JM, Bernard GR, Artigas A, Bakker J, Riess H, Basson BR, Charpentier J, Utterback BG, Vincent JL: Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple organ dysfunction: Data from the PROWESS trial. Intensive Care Med. 2003, 29: 894-903.PubMed

11.

Linder R, Frebelius S, Jansson K: Inhibition of the endothelial cell-mediated generation of activated protein C by direct and antithrombin dependant thrombin inhibitors. Blood Coagul Fibrinolysis. 2003, 14: 139-146. 10.1097/00001721-200302000-00004.CrossRefPubMed

12.

Kerlin BA, Yan SB, Isermann BH, Brandt JT, Sood R, Basson BR, Joyce DE, Weiler H, Dhainaut JF: Survival advantage associated with heterogeneous factor V leiden mutation in patients with severe sepsis and mouse endotoxemia. Blood. 2003, 102: 3085-3092. 10.1182/blood-2003-06-1789.CrossRefPubMed

13.

Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR: Low levels of Protein C are associated with poor outcomes in severe sepsis. Chest. 2001, 120: 915-922. 10.1378/chest.120.3.915.CrossRefPubMed

14.

Rosenberg RD, Aird WC: Vascular-bed-specific hemostasis and hypercoagulable states. N Eng J Med. 1999, 340: 1555-1564. 10.1056/NEJM199905203402007.CrossRef

15.

Gresele P, Stefania M, Berrettini M, Nenci GG, Schwarz HP, Semeraro N, Colucci M: Activated human protein C prevents thrombin-induced thromboembolism in mice. J Clinical Investigation. 1998, 101: 667-676.CrossRef

16.

Liaw PC, Esmon CT, Kahnamoui K, Schmidt S, Kahnamoui S, Ferrell G, Beaudin S, Julian JA, Weitz JI, Crowther M, Loeb M, Cook D: Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood. 2004, 104: 3958-3964. 10.1182/blood-2004-03-1203.CrossRefPubMed

17.

Nicolaes GA, Dhalback B: Activated protein C resistance (FV Leiden) and thrombosis: factor V mutations causing hypercoagulable states. Hematol Oncol Clin North Am. 2003, 17: 37-61. 10.1016/S0889-8588(02)00097-7.CrossRefPubMed

Title: A case report of a new pulmonary embolism occurring in a patient receiving continuous infusion of recombinant activated protein C
Authors: Bernard J Benedetto
Michael A Houston
Publication date: 01-12-2006
Publisher: BioMed Central
Published in: World Journal of Emergency Surgery / Issue 1/2006
Electronic ISSN: 1749-7922
DOI: https://doi.org/10.1186/1749-7922-1-23

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

A case report of a new pulmonary embolism occurring in a patient receiving continuous infusion of recombinant activated protein C

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2006

Introducing World Journal of Emergency Surgery

Repair of ascending aorta pseudoaneurysm without circulatory arrest in redo patient

Terrorist bombing

Emergency laparoscopy – current best practice

Arch vessel injury: geometrical considerations. Implications for the mechanism of traumatic myocardial infarction II

The consequences of obesity on trauma, emergency surgery, and surgical critical care